About TrialRedline

What does TrialRedline do?

TrialRedline tracks changes to clinical trial records on ClinicalTrials.gov, the public trial registry. It shows previous and updated completion dates, participant counts, study status and primary outcome measures, with links to the original records.

Who is it for?

Biotech analysts, investment researchers, competitive intelligence teams and journalists who need to check and cite changes to trial records.

How do I use it?

Search for a company, ticker or trial ID, then open a trial to compare the changes we have recorded. Create a free account to follow up to three listed companies and receive a weekly email digest. The FDA calendar also lists the regulatory events we have verified against sources.

What does it cover?

Initial coverage focuses on company-sponsored Phase 2/3 drug trials linked to US-listed companies. Historical records are partial; trial pages explain the gaps. TrialRedline does not provide patient matching, market prices, trading signals or investment recommendations.